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poster presentation 
Introduction: Helicobacter pylori (HP) is a part of the normal gastric flora and is the cause 
for more than 80% of gastric and 90% of duodenal ulcuses and gastric cancer (1-2 %). 
Methods: For 5 years we examined 1200 patients with dyspeptic disorders.We used the 
test for the presence of HP antibodies in serum (IgA and IgG). 
Results: 690 patients were positive for HP (from which 68 pregnant and 33 nursing 
women).Depending on the levels of titer of the antibodies and the confirmed diagnosis.the 
treatement were different.The patients with acute infection were taking the ProHefbis 
drops as an introductory therapy, 10-15 minutes prior to the triple therapy and after 
completing it,the patients go on taking ProHerbis three times a day during two months.In 
case the titer of the antibodies was not decreased after the first check up (45 days), the 
patients continued taking the drops in the next six months,2-3 times a day 20-
30.drops.20-30% of patients after the second check up (90 days) had no decrease of the 
titer of antibodies and they had the initial suffering because of the resistance to the 
antibiotics. We administered to these patients the quadruple therapy'and they go on 
taking ProHerbis drops in the next six months (20-30 drops),2-3 times a day.The nursing 
and pregnant women with positive HP antibodies were not allowed to take  triple therapy 
were taking 20-30 drops of PtoHerbis in period of 2-3 months. 
Conclusion: According to the researches performed in Belgrade at the Department of 
Microbiology of “Dragisa Misovic" Hospital,as well as at the Institute of virusology and 
immunology “Torlak”, the solution ProHerbis beside increasing the  
non-specific immunity shows particular bacteriostatical and bactericidal effect upon HP. 
We confirmed that after 45 days and especially after 90 days of the treatment. 
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